Consumir con un vaso lleno con agua.
Enrolling Metabolic Dysfunction-associated Steatohepatitis Drug: Placebo Drug: ECC4703 A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH The purpose of this study is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of efimosfermin in participants wi
Kidney and cardiovascular outcomes SURPASS-4 kidney composite HR 0.58, slower eGFR decline (-1.4 vs -3.6 mL/min/1.73m2/yr), UACR -6.8% vs +36.9%
"Although some of these substances may not be legally restricted in ordinary consumer contexts, we have proactively adopted stricter standards to define operational boundaries and our compliance efforts go beyond passive adherence and minimum legal requirements," the company said in a statement
Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS